InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. SPCX
3. MU
4. SPY
5. ACN
6. IBM
7. PRIM
8. PFE
9. TSLA
10. DPZ

Go back to InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition
(NASDAQ: INCR) Delayed: 1.06 -0.03 (2.75%)
Previous Close $1.09    52 Week High $57.11 
Open $1.07    52 Week Low $34.19 
Day High $1.07    P/E N/A 
Day Low $1.04    EPS $0.00 
Volume 71,225       

(NASDAQ: INCR) Delayed: 1.06 -0.03 (2.75%)
Previous Close $1.09    52 Week High $57.11 
Open $1.07    52 Week Low $34.19 
Day High $1.07    P/E N/A 
Day Low $1.04    EPS $0.00 
Volume 71,225